In sporadic ccRCC tumors, about 70% of them harbor biallelic inactivation of VHL through mutation, deletion, or hypermethylation of promoter that leads to the loss of its expression [1]. The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.